FDA Approves Lynparza to Treat BRCA-mutated Metastatic Breast Cancer

FDA Approves Lynparza to Treat BRCA-mutated Metastatic Breast Cancer  Breast Cancer News US OKs 1st drug aimed at women with inherited breast cancer  The Times Telegram FDA approves drug for women with breast cancer caused by BRCA, the 'Jewish gene'  San Diego Jewish Journal I was diagnosed with breast cancer. How genetic testing guided what to do next.  Genetic Literacy ProjectFull coverage

Read More ...
FDA Approves Lynparza to Treat BRCA-mutated Metastatic Breast Cancer published January 16, 2018 at 06:04AM. Original Source Link : http://ift.tt/2ELbdxl

loading...